LifeSciVC

AUGUST 5, 2024

In 2001, I was at Millennium Pharmaceuticals, one of the major players in the nascent field of genomics drug discovery, and that time has strong parallels to the changing state of drug development today. In fact, the Millennium of 2001 (pre-Takeda acquisition) had one drug approved which was Velcade (bortezomib).

Molecular Biology 90

Molecular Biology Production Drug Development Small Molecule 90

Drug Target Review

FEBRUARY 28, 2024

Dr Rochlin earned a PhD in Molecular Biology and Genetics from Weill Cornell Medical College, conducting research at Sloan Kettering Institute, and a BA in Biology from the University of Pennsylvania. Human γδ TCR repertoires in health and disease. Science 294(5542):605-609 (2001). Cells 9(40):800 (2020).

Therapies 105

Therapies Engineering Molecular Biology Science 105

Drug Target Review

FEBRUARY 15, 2024

Rising demand for animal protein has led to more factory farming, increasing the likelihood that diseases can spread among these animals then into humans. 5 Furthermore, ever larger numbers of humans are living in cities or travelling across borders, increasing the risk of diseases being transmitted person-to-person over a long range.

Drug Development 122

Drug Development Virus Vaccine Government 122

Codon

NOVEMBER 1, 2024

Amodei also imagines the ways AI could accelerate biological research and yield miraculous cures in the 21st century; everything from the prevention and treatment of nearly all infectious and inherited diseases to the elimination of most cancers. Biology experiments are also bottlenecked by the growth of organisms.

DNA 120

DNA RNA Molecular Biology Laboratories 120